Buffington Mohr McNeal »

Arrowhead Pharmaceuticals shares owned by Buffington Mohr McNeal

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Buffington Mohr McNeal from 13F filings

Historical chart of Buffington Mohr McNeal investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Buffington Mohr McNeal consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Buffington Mohr McNeal

Quarter filed Position value Share count Share price at filing
2025-03-31 $382k 30k 12.74
2024-12-31 $564k 30k 18.80
2024-09-30 $581k 30k 19.37

More positions owned by Buffington Mohr McNeal

Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares Core S&p 500 Etf Etf (IVV)
Costco Whsl Corp Stock (COST)
Microsoft Corp Stock (MSFT)
Technology Select Sector Spdr Fund Etf (XLK)
Jpmorgan International Research Enhanced Equity Etf Etf (JIRE)
Janus Henderson Aaa Clo Etf Etf (JAAA)
Amphenol Corp New Cl A Stock (APH)
Ishares Ibonds 2031 Corp Bond Etf (IBDW)
Ishares Ibonds 2026 Corp Bond Etf (IBDR)
Ishares Ibonds 2030 Corp Bond Etf (IBDV)
Ishares Core S&p Small Cap Etf Etf (IJR)
Jpmorgan Chase & Co Stock (JPM)
Visa Inc Com Cl A Stock (V)
Apple Stock (AAPL)

View all positions for Buffington Mohr McNeal

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Slate Path Capital
Geode Capital Management
Siren
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Ubs Global Asset Management Americas
Morgan Stanley
Baker Bros. Advisors
Marshall Wace

View all funds holding Arrowhead Pharmaceuticals